Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed Jun 14, 2019
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-12$1.68/sh+10,000$16,800→ 10,000 totalExercise: $1.68From: 2020-06-12Exp: 2029-06-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]100% vesting one year from date of grant